Bazel
Belgium
17
2026-04-30
The entities that hold a legal rights for patent applications filed by inventor D'Hondt Erik:
Erik D'Hondt from Bazel, BE has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF USING ANTI-EGF ANTIBODIES TO AUGMENT THE ACTIVITY OF BRAF AND KRAS INHIBITORS
#2 | 2025-02-27RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#3 | 2023-02-09SELF-ASSEMBLING SYNTHETIC PROTEINS
#4 | 2022-12-01METHODS AND COMPOSITIONS FOR USE OF GROWTH FACTOR ANTIBODIES IN COMBINATION WITH NON-TYROSINE TARGETING KINASE INHIBITORS
#5 | 2022-09-29STABILIZED CHIMERIC SYNTHETIC PROTEINS AND THERAPEUTIC USES THEREOF
#6 | 2022-05-19Recombinant proteins and their therapeutic uses
#7 | 2022-02-10Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors
#8 | 2021-01-14Synthetic proteins and therapeutic uses thereof
#9 | 2020-09-24Self-assembling synthetic proteins
#10 | 2020-02-13Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitors
#11 | 2019-11-28METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COMBINATION WITH TYROSINE KINASE INHIBITORS
#12 | 2018-06-14Recombinant proteins and their therapeutic uses
#13 | 2016-11-17METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COMBINATION WITH TYROSINE KINASE INHIBITORS
#14 | 2016-07-21RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
#15 | 2016-04-07Epidermal growth factor fusion proteins with mutant cholera toxin B subunits
#16 | 2014-09-04Recombinant proteins and their therapeutic uses
#17 | 2007-06-21Influenza vaccine
895534 ⎘